Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development ProgramsSummary GBI Research, the leading business intelligence provider, has released its latest report, "Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs", which provides key data, information and analysis of CRO industry. The report provides a comprehensive insight into the size of the CRO market, and includes forecasts, key reasons for outsourcing, technology developments affecting CRO's, public private partnerships, profiles of top CROs, drivers and restraints and deals analysis.
This report is built using data and information sourced from proprietary databases, primary and secondary research and uses in-house analysis from GBI Research's team of industry experts.
CRO industry market revenues were estimated to total $21.4 billion in 2010. In 2009 the revenues recorded were $19.1 billion. From 2009 to 2010 the industry grew at the rate of 12% which is considered to be very healthy in comparison to the other R&D industry growth. According to clinicaltrials.gov by November 2011, 43.9% of the clinical trials were carried out in the US. 22.9% of the trials were carried out in Europe. 11.6% of the trials were carried out in Asia and the rest of the clinical trials were carried out in Canada, Mexico, Australia, Middle East and Africa approximating 21.4% of the total clinical trials. GBI research estimates that the global R&D outsourcing market in 2010 was 25.3% of the total pharmaceutical R&D expenditure. The expenditure is estimated to increase at the rate of 5% annually and is expected to reach 37.1% of the total R&D expenditure by 2018. All the companies are looking to cut down the time for launch of drugs along with a reduction in the expenditure on R&D.Scope - Detailed overview of the CRO industry.
- Annualized market data and forecasts for the CRO market.
- Detailed overview of key reasons behind outsourcing, outsourcing service models and key drivers and restraints of the market.
- Analysis of the key technologies that affect CRO industry
- Analysis of public private partnerships with case studies.
- Company profiles of major CROs, key services offered, financial information and presence in APAC
- Analysis of partnership deals and M&A deals involving key companies.Reasons to buy - Develop market-entry and market expansion strategies by identifying areas for high growth and opportunities.
- Understand the factors shaping the CRO market.
- Identify the top players in the CRO market, financial revenues, geographical presence and key services offered.
- Analyze the key geographies that are lucrative markets for the outsourcing of clinical research.
- Analyze the trends in licensing and M&A deals and explore potential investment opportunities
- Understand upcoming trends that are poised to drive the future growth of the CRO industry.
1 Table of Contents1 Table of Contents 41.1 List of Tables 71.2 List of Figures 82 Contract Research Organization Market to 2018 - Introduction 102.1 GBI Research Report Guidance 103 Contract Research Organization Market to 2018 - Overview 113.1 Global Contract Research Organizations 113.1.1 Clinical Research Process 113.1.2 Drug Discovery Phase 113.1.3 Pre-Clinical Phase 113.1.4 Phase I 113.1.5 Phase II 113.1.6 Phase III 113.1.7 Review and Approval from Regulatory Agencies 123.1.8 Post-marketing Studies 123.2 Key Reasons Outsourcing Clinical Trials and Research Processes 123.2.1 Different Strategies Adopted by the Pharmaceutical Companies to Increase the Efficiency 123.2.2 Increase in R&D Costs Compared to Revenue Growth 133.2.3 Increasing Drug Failure Rates a Concern for Pharmaceutical Companies 143.2.4 Less Time Required to Launch a Product in the Market 143.2.5 Outsourcing to Site Management Organizations 153.2.6 Minimization of Development Risks through Risk Sharing 163.2.7 Contract Research Organizations can Effectively Manage the Trends in Regulations Governing Clinical Trials 164 Contract Research Organization Market to 2018 - Important Trends in Regulatory Aspects of Contract Research Organizations 174.1 New Pharmacovigilance Legislation 174.1.1 Reasons for Passing the New Legislation 174.2 Important Regulations by Food and Drug Administration in Proposal 174.2.1 Exculpatory Language to be Used in Informed Consent Forms 174.2.2 Risk-based Approach to Monitoring Strategies 174.3 Food and Drug Administration Motivating Contract Research Organizations to Use Adaptive Design in Drug Development 175 Contract Research Organization Market to 2018 - Technology Developments to Benefit Contract Research Organizations 185.1 Analytics and Intelligence to Meet Contract Research Organizations' High Expectations 185.2 Technological Developments in Clinical Research 185.2.1 Biomarkers 185.2.2 Nanotechnology 185.2.3 Genomics, Proteomics and Metabolomics 195.2.4 Toxicogenomics 195.2.5 Surgical Models 195.2.6 Transgenic Animal Models 205.2.7 Simulation Models 205.3 Information Technology in R&D 205.3.1 Data Management 205.3.2 Clinical Data Management System 215.3.3 Clinical Data Management Outsourcing 215.3.4 Deals in Clinical Trial Data Management Outsourcing 225.4 Technology Support Will Be Fundamental to Future of Personalized Medicine 235.5 eClinical Trial Solutions 245.5.1 Clinical Trial Management System 245.5.2 Electronic Data Capture 255.5.3 Using Virtual Technology to Reduce R&D Costs and Time 266 Contract Research Organization Market to 2018 - Internal Reorganization 276.1 Restructuring R&D 276.1.1 GlaxoSmithKline – Realigning Focus to Vaccines, Consumer Healthcare and Emerging Markets 286.1.2 Pfizer – Redefining the Research Focus and Outsourcing the Rest 296.1.3 AstraZeneca – Consolidating R&D Facilities with Narrowed Therapeutic Focus 306.1.4 Sanofi – Combining Workforce Consolidation with Externalization to Safeguard Future Revenue 317 Contract Research Organization Market to 2018 - Public-Private Partnerships 327.1 Public-Private Partnerships 327.1.1 Public-Private Partnerships for R&D in the Pharmaceutical Industry 327.2 Private-Government Partnerships 327.2.1 Innovative Medicine Initiative in Europe 327.2.2 Cooperative Research and Development Agreements in the US 347.2.3 Cooperative Research and Development Agreement for Pharmaceutical R&D 357.2.4 Small Business Innovation Research Program 367.2.5 Public-Private Partnership in India 377.2.6 Blockbusters from the US Funding 377.2.7 Technology Transfer Issues 377.2.8 Laws Enabling Technology Transfer in the US 407.3 Open-source R&D 407.4 Crowdsourcing 407.4.1 Applicability of Crowdsourcing to the Pharmaceutical Industry 418 Contract Research Organization Market to 2018 - Market Characterization 428.1 Global Clinical Trial Market 428.2 Global Pharmaceutical R&D Outsourcing Market 438.3 Global Contract Research Organization Market by Geography 448.4 Trend Analysis of Contract Research Organization Market by Geography 458.5 Global Contract Research Organization Market by Phase 468.6 Trend Analysis of Contract Research Organization Market by Phase 479 Contract Research Organization Market to 2018 - Geographical Landscape 489.1 Emerging Regions in the Global Contract Research Organization Market: Argentina 489.2 Domestic Contract Research Organization Profiles 499.2.1 Abel Santos & Asociados 499.2.2 Activa CRO 509.2.3 Blanchard & Asociados 519.2.4 EGCP 529.2.5 Klixar 539.2.6 LatinClin 549.2.7 Mmatiss 559.2.8 Estudios Clínicos Latinoamérica 569.3 Emerging Regions in the Global Contract Research Organization Market: India 579.4 Domestic Contract Research Organization Profiles 589.4.1 Reliance Life Sciences 589.4.2 Asian Clinical Trials 599.4.3 DiagnoSearch Life Sciences 609.4.4 ClinInvent 619.4.5 Synchron Research Services Pvt Ltd 629.4.6 Lambda Therapeutic Research Ltd 639.4.7 GVK Biosciences Pvt Ltd 649.4.8 Veeda Clinical Research Ltd 659.4.9 Ecron Acunova 669.4.10 Siro Clinpharm Pvt Ltd 679.5 Emerging Regions in the Global Contract Research Organization Market: China 689.6 Domestic Contract Research Organizations 699.6.1 Boji Medicine Services Co. Ltd 699.6.2 Giant Med-Pharma Services Inc 709.6.3 InCrom 719.6.4 Pharmaron 729.6.5 Venturepharm Service Group 7310 Contract Research Organization Market to 2018 - Competitive Landscape 7410.1 Overview 7410.2 Market Share Analysis 7510.3 Quintiles Transnational Corp 7710.3.1 Business Description 7710.3.2 Recent M&A Deals and Strategic Alliances 7810.4 Covance Inc 8010.4.1 Business Description 8010.4.2 Recent M&A Deals and Alliances 8110.5 Pharmaceutical Product Development Inc 8210.5.1 Business Description 8210.5.2 Recent M&A Deals and Alliances 8310.6 Charles River Laboratories International, Inc 8610.6.1 Business Description 8710.6.2 Recent M&A Deals and Alliances 8810.7 Parexel International 9010.7.1 Business Description 9010.7.2 Recent M&A Deals and Alliances 9111 Contract Research Organization Market to 2018 - Appendix 9311.1 Market Definitions 9311.2 Abbreviations 9311.3 Note 9511.4 Research Methodology 9511.4.1 Coverage 9511.4.2 Secondary Research 9511.4.3 Primary Research 9611.4.4 Expert Panel Validation 9611.4.5 Section-wise Research Methodology 9611.5 Contact Us 9711.6 Disclaimer 9811.7 Sources 98
1.1 List of Tables
Table 1: Contract Research Organization Market to 2018, Comparison of Growth of R&D Expenditure vs. Growth Turnover for the Top 10 Pharmaceutical Companies, 2004–2010 13Table 2: Contract Research Organization Market to 2018, Global, Revenue ($bn), 2008–2018 42Table 3: Contract Research Organization Market to 2018, Global, R&D Outsourcing Market (%), 2008–2018 43Table 4: Contract Research Organization Market to 2018, Global, Revenue by Geography ($bn), 2010–2018 44Table 5: Contract Research Organization Market to 2018, Global, Trend Analysis by Geography (%), 2010–2018 45Table 6: Contract Research Organization Market to 2018, Global, Revenue by Phase ($bn), 2010–2018 46Table 7: Contract Research Organization Market to 2018, Global, Trend Analysis by Phase,(%), 2010–2018 47Table 8: Contract Research Organization Market to 2018, Clinical Trial Market, Argentina ($m), 2008–2018 48Table 9: Contract Research Organization Market to 2018, Clinical Trial Market, India , ($m), 2008–2018 57Table 10: Contract Research Organization Market to 2018, Clinical Trial Market, China , ($m), 2008–2018 68Table 11: Contract Research Organization Market to 2018, Quintiles, Strategic Consolidations, 2005–2011 78Table 12: Contract Research Organization Market to 2018, Covance, Strategic Consolidations, 2005–2011 81Table 13: Contract Research Organization Market to 2018, Pharmaceutical Product Development, Strategic Consolidations, 2006–2011 83Table 14: Contract Research Organization Market to 2018, Charles River Laboratories, Strategic Consolidations, 2005–2011 88Table 15: Contract Research Organization Market to 2018, Parexel, Strategic Consolidations, 2005–2011 91